Related Experiment Video
Updated: May 26, 2026

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Analysis of commercial and public bioactivity databases
Pekka Tiikkainen1, Lutz Franke
1Merz Pharmaceuticals GmbH, Eckenheimer Landstrasse 100, 60318 Frankfurt am Main, Germany. pekka.tiikkainen@merz.de
Merging public and commercial bioactivity databases created a unified resource. Despite common inconsistencies, each database offers unique small molecule activity data, making diverse data sources valuable for chemoinformatics research.
Area of Science:
- Chemoinformatics
- Bioactivity Data Analysis
- Database Merging
Background:
- Bioactivity databases are crucial for chemoinformatics, containing target protein and small molecule binding data.
- Existing databases are often siloed, requiring integration for efficient data retrieval and analysis.
Purpose of the Study:
- To create a unified bioactivity metabase by merging public and commercial databases.
- To assess the data overlap and complementarity between different commercial and public vendors.
- To quantify inconsistencies in activity data across various sources.
Main Methods:
- Standardization of molecular representation, target information, and activity data from vendor databases.
- Development of a single relational database for streamlined data retrieval.
- Comparative analysis of data points from the same scientific articles across multiple vendors.
Main Results:
- Each data source contains unique small molecule activity data due to the citation of different scientific articles.
- Significant inconsistencies were observed when comparing data points derived from the same article across vendors.
- The overlap between commercial and public databases is not complete, indicating complementary data.
Conclusions:
- Merging diverse bioactivity databases into a metabase enhances data accessibility for researchers.
- Despite inconsistencies, utilizing multiple databases remains beneficial due to incomplete data overlap.
- Inconsistencies highlight the need for careful data curation and validation in chemoinformatics.
More Related Videos
08:00Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Related Concept Videos
Bioactivation and Tissue Toxicity
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...